<p>At week 5, mock vaccinated mice or mice vaccinated with vaccines (3 µg) were challenged intranasally with the mouse-adapted influenza ma-NC/99 virus (2.6×10<sup>5</sup> pfu). Mice were monitored daily for weight loss, activity, and survival. Body weight is plotted as percentage of the average initial weight. Mice that lost greater than 20% body weight were sacrificed.</p
<p>Mice were immunized and boosted with various doses of Ad4 and Ad5 expressing the H5-Con consensus...
<p>Mice were immunized and boosted with various doses of Ad4 and Ad5 expressing the H3-Con consensus...
<p>Survival rates (A, C) and average body weight loss (B, D) of BALB/c (A, B) or C57BL/6 (C, D) mice...
<p>At week 5, mice vaccinated with clade 2-dervied vaccines were challenged intranasally with a leth...
<p>A–B: Protection against A/California/04/2009 virus challenge. Mice intramuscularly immunized with...
<p>At week 30 post immunization, H5N1 VLP immunized and control (PBS or 5 µg inactivated PR/8/34 H1N...
<p>At 18 days following the last immunization, all mice in study group B were intranasally challenge...
<p>Mice (n = 6/groups) were immunized subcutaneously on day 0 and 28. All groups were challenged int...
<p>Six-week-old BALB/c mice were inoculated intranasally with 1000EID<sub>50</sub> of the recombinan...
<p>BALB/c mice (n = 6) were immunized on day 0 and 21 with rNP (10 µg/dose) alone or co-administered...
<p>The immunized mice were intranasally challenged with the reassortant RG2 (clade 2.1) or NIBRG23 (...
<p>Mice (groups of 5) were mock-immunized with PBS or immunized with either 10<sup>3</sup> or 10<sup...
<p>A. Body weight loss in vaccinated/challenged C57/B6 mice. Mice were vaccinated with Pol1, Pol2, A...
<p>Mice in groups of 5 were vaccinated with MVA or MVA-HA at the doses indicated in the legend. Boos...
<p>Groups of 10 BALB/c mice were vaccinated with 10<sup>6.5</sup> TCID<sub>50</sub> of NDV-H5 or NDV...
<p>Mice were immunized and boosted with various doses of Ad4 and Ad5 expressing the H5-Con consensus...
<p>Mice were immunized and boosted with various doses of Ad4 and Ad5 expressing the H3-Con consensus...
<p>Survival rates (A, C) and average body weight loss (B, D) of BALB/c (A, B) or C57BL/6 (C, D) mice...
<p>At week 5, mice vaccinated with clade 2-dervied vaccines were challenged intranasally with a leth...
<p>A–B: Protection against A/California/04/2009 virus challenge. Mice intramuscularly immunized with...
<p>At week 30 post immunization, H5N1 VLP immunized and control (PBS or 5 µg inactivated PR/8/34 H1N...
<p>At 18 days following the last immunization, all mice in study group B were intranasally challenge...
<p>Mice (n = 6/groups) were immunized subcutaneously on day 0 and 28. All groups were challenged int...
<p>Six-week-old BALB/c mice were inoculated intranasally with 1000EID<sub>50</sub> of the recombinan...
<p>BALB/c mice (n = 6) were immunized on day 0 and 21 with rNP (10 µg/dose) alone or co-administered...
<p>The immunized mice were intranasally challenged with the reassortant RG2 (clade 2.1) or NIBRG23 (...
<p>Mice (groups of 5) were mock-immunized with PBS or immunized with either 10<sup>3</sup> or 10<sup...
<p>A. Body weight loss in vaccinated/challenged C57/B6 mice. Mice were vaccinated with Pol1, Pol2, A...
<p>Mice in groups of 5 were vaccinated with MVA or MVA-HA at the doses indicated in the legend. Boos...
<p>Groups of 10 BALB/c mice were vaccinated with 10<sup>6.5</sup> TCID<sub>50</sub> of NDV-H5 or NDV...
<p>Mice were immunized and boosted with various doses of Ad4 and Ad5 expressing the H5-Con consensus...
<p>Mice were immunized and boosted with various doses of Ad4 and Ad5 expressing the H3-Con consensus...
<p>Survival rates (A, C) and average body weight loss (B, D) of BALB/c (A, B) or C57BL/6 (C, D) mice...